Paolo Tarantino, Research Fellow Dana-Farber Cancer Institute and Harvard Medical School, shared a post by Sarah Sammons, Breast Medical Oncologist and Senior Physician at Dana-Farber’s Breast Oncology Center on X, adding:
“Sarah: I feel so incredibly fortunate for having had you as a Dana-Farber’s Breast Oncology colleague, mentor, friend.. and desk neighbor! I’ve been so inspired by your unique mix of knowledge, wit, energy and passion for what you do.
Best of luck with your new stellar adventure in Maryland!”
Quoting Sarah Sammons‘s post:
“Today is my last day at Dana-Farber Cancer Institute.
DFCI is a place unlike any other. The standard of care, culture of intellectual curiosity, the relentless focus on patients. A special thank you to Dr. Sara Tolaney and Dr. Nancy Lin for your gracious mentorship. There is no better place.
Our hearts are full. We’re heading home to family.
Soon I’m joining the UMGCCC.
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center as Co-Leader of Breast Oncology, with a deep commitment to growing the breast program for the people of Baltimore and the DMV.
We plan to initiate a new multidisciplinary CNS Metastases Clinic, home to Maryland’s only Proton Center.
UMGCCC is one of 56 NCI-designated comprehensive cancer centers in the country, moving into a brand new state-of-the-art building, and on the rise under the visionary leadership of Dr. Taofeek Owonikoko.
To every patient who trusted me: thank you and you are in the best hands.”
Other articles about Breast Cancer on OncoDaily.
